Skip to main content
. Author manuscript; available in PMC: 2019 May 17.
Published in final edited form as: Comput Methods Biomech Biomed Engin. 2017 Sep 20;20(13):1474–1482. doi: 10.1080/10255842.2017.1378352

Table 2.

Results corresponding to 10 adults plus the average adult subject. Symbol “*” indicates statistical significance (p<0.01) with respect to the closed-loop insulin only therapy (IO) and symbol “‡” indicates statistical significance (p<0.01) with respect to the non-coordinated hormonal control (NC). A double symbol (e.g. “‡‡”) indicated statistical significance of p<0.05.

Glucose
mg/dl
%IN [70,140]
mg/dl
%<70
mg/dl
%>140
mg/dl
%IN [70,180]
mg/dl
%>180
mg/dl
IO 131.8±5.9 58.7±6.3 5.3±2.1 35.8±5.3 81.1±6.0 13.5±5.5
NC 136.03±6.8* 61.37±6.5* 1.53±1.0* 37.09±6.4 84.53±5.7* 13.93±5.8
CO 130.0±5.9* 66.75±5.8* 1.79±1.5* 31.4±6.0* 88.1±4.7* 10.0±4.9*
STD
mg/dl
RI LBGI HBGI INSULIN
U per day
GLUCAGON
mg per day
IO 42.7±7.3 4.6±1.3 1.6±0.7 2.9±1.0 41.2±9.2 0±0
NC 38.10±8.0* 3.48±1.12* 0.45±0.15* 3.03±1.11 43.61±9.92* 0.64±0.52*
CO 35.44±6.89* 2.92±0.84* 0.56±0.24*‡‡ 2.35±0.85* 44.99±10.25* 0.70±0.53*